Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers

Artificial DNA: PNA and XNA

Volumn 2, Issue 3, 2011, Pages 90-99

  Shiraishi, Takehiko ^a   Nielsen, Peter E ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antisense; Carrier; Cell penetrating peptide (CPP); Cellular delivery; Peptide nucleic acid (PNA); siRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARGININE; CHLOROQUINE; DECANOIC ACID; DRUG CARRIER; PEPTIDE NUCLEIC ACID CELL PENETRATING PEPTIDE CONJUGATE; SINGLE STRANDED RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG UPTAKE; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; HELA CELL; LUCIFERASE GENE; RNA SPLICING;

CELL-PENETRATING PEPTIDES; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HELA CELLS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE NUCLEIC ACIDS; RNA SPLICING; TRANSFECTION;

EID: 83155180672     PISSN: 1949095X     EISSN: 19490968     Source Type: Journal    
DOI: 10.4161/adna.2.3     Document Type: Article

References (40)

1. Opalinska JB, Gewirtz AM. Nucleic-acid therapeutics: basic principles and recent applications. Nat Rev Drug Discov 2002; 1:503-14. PMID:12120257; DOI:10.1038/nrd837.
2. Manoharan M. Oligonucleotide conjugates as potential antisense drugs with improved uptake, bio distribution, targeted delivery, and mechanism of action. Antisense Nucleic Acid Drug Dev 2002; 12:103-28; PMID:12074364; DOI:10.1089/108729002760070849.
3. Ghosh C, Iversen PL. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers. Antisense Nucleic Acid Drug Dev 2000; 10:263-74; PMID:10984120; DOI:10.1089/108729000421448.
4. Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annu Rev Biochem 2005; 74:711-38; PMID:15952901; DOI:10.1146/annurev biochem.74.050304.091637.
5. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003; 327:761-6; PMID:12654261; DOI:10.1016/S0022-2836(03)00181-5.
6. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 2005; 102:12177-82; PMID:16091473; DOI:10.1073/ pnas.0501753102.
7. Grzelinski M, Urban-Klein B, Martens T, Lamszus K, Bakowsky U, Hobel S, et al. RNA interference-mediated gene silencing of pleiotrophin through polyeth-ylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther 2006; 17:751-66; PMID:16839274; DOI:10.1089/hum.2006.17.751.
8. Ezzat K, El Andaloussi S, Abdo R, Langel U. Peptide-based matrices as drug delivery vehicles. Curr Pharm Des 2010; 16:1167-78; PMID:20030616; f DOI:10.2174/138161210790963832.y
9. Dietz GP, Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 2004; 27:85-131; PMID:15485768; DOI:10.1016/j. mcn.2004.03.005.
10. Fischer R, Fotin-Mleczek M, Hufnagel H, Brock R. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides. ChemBioChem 2005; 6:2126-42; PMID:16254940; DOI:10.1002/cbic.200500044.
11. Zatsepin TS, Turner JJ, Oretskaya TS, Gait MJ. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents. Curr Pharm Des 2005; 11:3639-54; PMID:16305500; DOI:10.2174/138161205774580769.
12. Cesarone G, Edupuganti OP, Chen CP, Wickstrom E. Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resis-tant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem 2007; 18:1831-40; PMID:17922544; DOI:10.1021/bc070135v
13. Muratovska A, Eccles MR. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett 2004; 558:63-8; PMID:14759517; DOI:10.1016/S0014-5793(03)01505-9.
14. Deshayes S, Morris M, Heitz F, Divita G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 2008; 60:537-47; PMID:18037526; DOI:10.1016/j. addr.2007.09.005.
15. Meade BR, Dowdy SF Enhancing the cellular uptake of siRNA duplexes following non covalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 2008; 60:530-6; PMID:18155315; DOI:10.1016/j.addr.2007.10.004.
16. Meade BR, Dowdy SF. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 2007; 59:134-40; PMID:17451840; DOI:10.1016/j.addr.2007.03.004.
17. Unnamalai N, Kang BG, Lee WS. Cationic oligo-peptide-mediated delivery of dsRNA for post-tran-scriptional gene silencing in plant cells. FEBS Lett 2004; 566:307-10; PMID:15147914; DOI:10.1016/j. febslet.2004.04.018.
18. Simeoni F, Morris MC, Heitz F, Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res 2003; 31:2717-24; PMID:12771197; DOI:10.1093/nar/gkg385.
19. Veldhoen S, Laufer SD, Trampe A, Restle T Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res 2006; 34:6561-73; PMID:17135188; DOI:10.1093/ nar/gkl941.
20. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001; 276:3254-61; PMID: 11024024; DOI:10.1074/jbc. M006701200.
21. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002; 277:2437-43; PMID:11711547; DOI:10.1074/jbc.M110017200.
22. Console S, Marty C, Garcia-Echeverria C, Schwendener R, Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to' cell surface glycosaminoglycans. J Biol Chem 2003; 278:35109-14; PMID:12837762; DOI:10.1074/jbc.M301726200.
23. Foerg C, Ziegler U, Fernandez-Carneado J, Giralt E, Rennert R, Beck-Sickinger AG, et al. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 2005; 44:72-81; PMID:15628847; DOI:10.1021/bi048330+.
24. Mano M, Teodosio C, Paiva A, Simoes S, Pedroso de Lima MC. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem J 2005; 390:603-12; PMID:15907190; DOI:10.1042/ BJ20050577.
25. Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 2005; 57:529-45; PMID:15722162; DOI:10.1016/j. addr.2004.10.010.
26. Turner JJ, Jones S, Fabani MM, Ivanova G, Arzumanov AA, Gait MJ. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol Dis 2007; 38:1-7; PMID:17113327; DOI:10.1016/j. bcmd.2006.10.003.
27. Dassie JP, Liu XY, Thomas GS, Whitaker RM, Thiel KW, Stockdale KR, et al. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol 2009; 27:839-49; PMID:19701187; DOI:10.1038/ nbt.1560.
28. Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M, et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat Biotechnol 2009; 27:925-32; PMID:19749770; DOI:10.1038/nbt.1564.
29. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyam-ide. Science 1991; 254:1497-500; PMID:1962210; DOI:10.1126/science.1962210.
30. Doyle DF, Braasch DA, Simmons CG, Janowski BA, Corey DR. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry 2001; 40:53-64; PMID:11141056; DOI:10.1021/ bi0020630.
31. Fisher L, Soomets U, Cortes Toro V, Chilton L, Jiang Y, Langel U, et al. Cellular delivery of a double-stranded oligonucleotide NFkappaB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide. Gene Ther 2004; 11:1264-72; PMID:15292915; DOI:10.1038/sj.gt.3302291.
32. Kitamatsu M, Kubo T, Matsuzaki R, Endoh T, Ohtsuki T, Sisido M. Carrier PNA for shRNA delivery into cells. Bioorg Med Chem Lett 2009; 19:3410-3; PMID:19481448; DOI:10.1016/j.bmcl.2009.05.031.
33. Koppelhus U, Shiraishi T, Zachar V, Pankratova S, Nielsen PE. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Bioconjug Chem 2008; 19:1526-34; PMID:18646838; DOI:10.1021/ bc800068h.
34. Shiraishi T, Pankratova S, Nielsen PE. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chem Biol 2005; 12:923-9; PMID:16125104; DOI:10.1016/j.chembiol.2005.06.009.
35. Midoux P, Kichler A, Boutin V, Maurizot JC, Monsigny M. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjug Chem 1998; 9:260-7; PMID:9548543; DOI:10.1021/bc9701611.
36. Midoux P, LeCam E, Coulaud D, Delain E, Pichon C. Histidine containing peptides and polypeptides as nucleic acid vectors. Somat Cell Mol Genet 2002; 27:27-47; PMID:12774939; DOI:10.1023/A:1022931923153.
37. Pichon C, Goncalves C, Midoux P. Histidine-rich peptides and polymers for nucleic acids delivery. Adv Drug Deliv Rev 2001; 53:75-94; PMID:11733118; DOI:10.1016/S0169-409X(01)00221-6.
38. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432:173-8; PMID:15538359; DOI:10.1038/nature03121.
39. Janout V, Jing B, Regen SL. Molecular umbrella-assisted transport of an oligonucleotide across cholesterol-rich phospholipid bilayers. J Am Chem Soc 2005; 127:15862-70; PMID:16277529; DOI:10.1021/ja053930x.
40. Christensen L, Fitzpatrick R, Gildea B, Petersen KH, Hansen HF, Koch T, et al. Solid-phase synthesis of peptide nucleic acids. J Pept Sci 1995; 1:175-83; PMID:9222994; DOI:10.1002/psc.310010304.